(Q36540048)

14 August 2017

1 reference

title

Enhancing validity in co-occurring disorders treatment research (English)

1 reference

14 August 2017

2

Robert E Drake

1 reference

14 August 2017

Gregory J McHugo

1

1 reference

14 August 2017

Mary F Brunette

3

1 reference

14 August 2017

Haiyi Xie

4

1 reference

14 August 2017

Susan M Essock

5

1 reference

14 August 2017

Alan I Green

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

18 July 2006

1 reference

14 August 2017

Schizophrenia Bulletin

1 reference

14 August 2017

32

1 reference

14 August 2017

4

1 reference

14 August 2017

655-665

1 reference

Using behavioral reinforcement to improve methadone treatment participation

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Future directions in preventing relapse to substance abuse among clients with severe mental illnesses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Qualitative research in psychiatry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

External validity of randomised controlled trials: "to whom do the results of this trial apply?".

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

An experimental design for the development of adaptive treatment strategies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Mediators and moderators of treatment effects in randomized clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

A comparison of methods to test mediation and other intervening variable effects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Problem drinkers: evaluation of a stepped-care approach.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Determinants of medication compliance in schizophrenia: empirical and clinical findings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Family support and substance use outcomes for persons with mental illness and substance use disorders.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Complications of severe mental illness related to alcohol and drug use disorders.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Clinically significant change: Jacobson and Truax (1991) revisited

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Increasing substance abuse treatment compliance for persons with traumatic brain injury

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Untangling the web: an approach to analyzing the impacts of individually tailored, multicomponent treatment interventions.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Evaluation of treatment programs for persons with severe mental illness: moderator and mediator effects.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Adequacy of treatment for serious mental illness in the United States.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Social patterns of substance use among people with dual diagnoses

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Improving primary care for depression in late life: the design of a multicenter randomized trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Medication noncompliance and substance abuse among patients with schizophrenia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632278

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL009

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

21 January 2018

1 reference

12 December 2020

Normative comparisons for the evaluation of clinical significance

1 reference

12 December 2020

A strategy for optimizing and evaluating behavioral interventions

1 reference

12 December 2020

Treatment of patients with psychiatric and psychoactive substance abuse disorders

1 reference

12 December 2020

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBL009

1 reference

release_thogq2yakncxfj2r573hnf6woe

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/thogq2yakncxfj2r573hnf6woe

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

16849398

1 reference